CXCL8 and head and neck squamous cell carcinoma: As shown in Figure 3A, IL-8 treatment of three types of HNSCC and DOK cell lines, at a concentration of 1–100 ng/ml, and especially at 10–100 ng/ml for 72 h slightly increased the proliferation of HNSCC cells, but not DOK cells.